BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $546,850 | +32.2% | 3,753 | +7.6% | 0.02% | +60.0% |
| Q1 2022 | $413,691 | -78.8% | 3,489 | -75.4% | 0.02% | -44.4% |
| Q4 2021 | $1,951,114 | -3.4% | 14,158 | -2.6% | 0.03% | -6.9% |
| Q3 2021 | $2,019,335 | +126.3% | 14,537 | +11.4% | 0.03% | +123.1% |
| Q1 2021 | $892,309 | -22.9% | 13,055 | -3.3% | 0.01% | -23.5% |
| Q4 2020 | $1,157,514 | +10.1% | 13,505 | -6.0% | 0.02% | -10.5% |
| Q2 2020 | $1,050,883 | +100.0% | 14,374 | +14.1% | 0.02% | +111.1% |
| Q3 2019 | $525,505 | +15.2% | 12,596 | +21.0% | 0.01% | +12.5% |
| Q2 2019 | $455,985 | -14.9% | 10,413 | 0.0% | 0.01% | -20.0% |
| Q1 2019 | $535,957 | +39.2% | 10,413 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $385,073 | – | 10,413 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 857,494 | $55,746,000 | 45.68% |
| RP Management, LLC | 2,111,111 | $137,243,000 | 20.57% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,074,800 | $134,883,000 | 17.78% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,310,261 | $85,180,000 | 9.56% |
| TANG CAPITAL MANAGEMENT LLC | 599,091 | $38,947,000 | 7.05% |
| Blackcrane Capital, LLC | 44,112 | $2,868,000 | 6.69% |
| ARS Investment Partners, LLC | 559,574 | $36,378,000 | 5.72% |
| Eversept Partners, LP | 321,581 | $20,905,981 | 4.64% |
| Avidity Partners Management LP | 1,284,200 | $83,486,000 | 3.87% |
| ARDSLEY ADVISORY PARTNERS LP | 257,000 | $16,708,000 | 3.22% |